|
|
|
|
| LEADER |
02513nam a2200325 u 4500 |
| 001 |
EB000944178 |
| 003 |
EBX01000000000000000737768 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
150223 r ||| eng |
| 020 |
|
|
|a 0309164192
|
| 020 |
|
|
|a 9780309164191
|
| 050 |
|
4 |
|a RA643.83
|
| 245 |
0 |
0 |
|a HIV screening and access to care
|h Elektronische Ressource
|b exploring the impact of policies on access to and provision of HIV Care
|c Committee on HIV Screening and Access to Care, Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies
|
| 260 |
|
|
|a Washington, D.C.
|b National Academies Press
|c c2011, 2011
|
| 300 |
|
|
|a xvii, 96 p.
|b ill.
|c 23 cm
|
| 505 |
0 |
|
|a Includes bibliographical references (p.65-73)
|
| 505 |
0 |
|
|a Machine generated contents note: HIV Screening and Access to Care: Exploring the Impact of Policies on Access to and Provision of HIV Care -- Report Organization -- Background -- Policies That Promote or Inhibit Clinical Care Services Among Agencies at the Federal Level, State Level, or Between Federal and State Agencies -- How Federal and State Agencies Can Provide More Integrated HIV Care Services -- HIV Medication Adherence Programs -- Payment for Treatment of Earlier Stage HIV Infection -- Conclusions -- REFERENCES -- APPENDIXES -- A.Biographical Sketches of Committee Members -- B.Workshop Agenda -- C.Biographical Sketches of Workshop Speakers
|
| 653 |
|
|
|a Health Services Accessibility
|
| 653 |
|
|
|a United States
|
| 653 |
|
|
|a Health Policy
|
| 653 |
|
|
|a HIV Infections / diagnosis
|
| 653 |
|
|
|a HIV Infections / therapy
|
| 710 |
2 |
|
|a Institute of Medicine (U.S.)
|b Committee on HIV Screening and Access to Care
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK209551
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 856 |
4 |
0 |
|u http://www.nap.edu/catalog.php?record_id=13057
|3 Volltext
|n Provider site
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a "With the widespread use of highly active anti-retroviral treatment (HAART), HIV has become a chronic, rather than a fatal, disease. But for their treatment to succeed, patients require uninterrupted care from a health care provider and uninterrupted access to anti-HIV medications. The IOM identifies federal, state, and private health insurance policies that inhibit HIV-positive individuals from initiating or continuing their care."--Publisher's description
|